经尿道等离子前列腺剜除术对前列腺增生患者IPSS、QoL评分及Qmax的影响  

Effect of transurethral plasma enucleation of prostate on IPsS,QoL score and Q,in patients with benign prostatic hyperplasia

作　　者：吴沛珊[1] 宋波[1] 孔广起[1] 赵玲娜 Wu Peishan;Song Bo;Kong Guangqi;Zhao Lingna(Department of Urology,Beijing Luhe Hospital,Capital Medical University,Beijing 101199,China)

机构地区：[1]首都医科大学附属北京潞河医院泌尿外科,北京101199

出　　处：《中国男科学杂志》2023年第4期74-78,共5页Chinese Journal of Andrology

基　　金：潞河医院医院管理相关研究基金项目(KJ2019CX003-07)。

摘　　要：目的探究经尿道等离子前列腺剜除术(TUKEP;Transurethral plasma enucleation of the prostate)对前列腺增生患者IPSS、QoL评分及Qmax的影响。方法选取2017年1月1日至2021年9月1日我院收治的前列腺增生患者100例为研究对象,按照患者采取的治疗方式不同分为观察组和对照组各50例,其中对照组患者采取经尿道前列腺电切术(TURP;Transurethral electrical resection of the prostate)治疗,观察组采取经尿道等离子前列腺剜除术治疗,对比两组患者手术情况(术中出血量、手术时间、前列腺切除质量、膀胱冲洗时间、导尿管留置时间等)、治疗前后残留尿量(PVR;postvoid residual)、国际前列腺症状评分(IPSS;International Prostate Symptoms Score)、患者生活质量(QoL;quality oflife)评分、最大尿流率(Qmax;Maximum urinary flow rate)情况,术后并发症情况。结果观察组患者的手术时间、膀胱冲洗时间、导尿管留置时间、术中出血量分别为(106.45±18.29)min、(58.24±17.23)mL、(3.53±0.92)d、(19.45±1.62)h,均显著短于对照组(132.76±32.11)min、(120.05±26.79)mL、(5.73±1.13)d、(27.74±4.12)h,切除组织质量(55.76±16.43)g高于对照组(48.27±24.89)g(P<0.05);术后3个月观察组IPSS评分、RUV值(5.95±1.08)分、(21.38±2.12)mL显著显著低于对照组(7.10±0.94)分、(24.01±2.31)mL,Qmax值(20.57±0.97)mL/s显著高于对照组(17.88±1.16)mL/s(P<0.05),术后两组QOL评分未见显著差异(P>0.05);观察组患者的并发症发生率5.00%(3/50)显著低于对照组16.00%(8/50)(P<0.05)。结论经尿道等离子前列腺剜除术对前列腺增生患者治疗效果显著,能有效改善IPSS、QoL评分及Qmax,且患者术后并发症少,安全性较高。Objective To explore the effect of transurethral plasma prostate enucleation(TUKEP;Transurethral plasma enucleation of the prostate)on IPSS,QoL score,and Qmax in patients with prostatic hyperplasia.Methods 100 patients with Phyperplasia admitted to our hospital from January 1,2017 to September 1,2021 were selected as the subjects of this study.According to the different treatment methods adopted by patients,50 cases of observation group and control group,the control group underwent transurethral electric resection of the prostate(TURP;Transurethral electrical resection of the prostate),the observation group underwent transurethral plasma enucleation of the prostate,observe and compare the surgical conditions of the two groups(intraoperative blood loss,operation time,quality of prostate resection,bladder washing time,indwlling catheter time,etc.),residual urine volume before and after treatment(PVR;postvoid residual),international prostate symptom score(IPSS),patient quality of life(QoL;quality of life)score,maximum urinary flow rate(Qmax;Maximum urinary flow rate),postoperative complications.Results The operation time,bladder irrigation time,indwelling catheter time,and intraoperative blood loss of the observation group were(106.45±18.29)min,(58.24±17.23)mL,(3.53±0.92)d,and(19.45±1.62)h respectively,and significantly shorter than the control group(132.76±32.11)min,(120.05±26.79)mL,(5.73±1.13)d,(27.74±4.12)h.The excised tissue weight(55.76±16.43)g was higher than that of the control group(48.27±24.89)g,the difference was statistically significant(P<0.05);3 months after the operation,the two groups of patients were improved to a certain extent,and the IPSS score,RUV value of the observation group were(5.95±1.08),(21.38±2.12)mL was significantly lower than the control group(7.10±0.94),(24.01±2.31)mL,Qmax value(20.57±0.97)mL/s.It was significantly higher than the control group(17.88±1.16)mL/s,and the difference was statistically significant(P<0.05).There was no significant difference in the QoL score

关 键 词：经尿道前列腺切除术 前列腺增生 治疗结果 手术后并发症 

分 类 号：R697.32[医药卫生—泌尿科学] R699.8[医药卫生—外科学]